These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25962315)

  • 1. Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.
    Choi WT; Rabinovitch PS; Wang D; Westerhoff M
    Hum Pathol; 2015 Jul; 46(7):939-47. PubMed ID: 25962315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of DNA Flow Cytometric Analysis of Paraffin-embedded Tissue in the Risk Stratification and Management of 'Indefinite for dysplasia' in Patients With Inflammatory Bowel Disease.
    Wen KW; Rabinovitch PS; Wang D; Huang D; Mattis AN; Choi WT
    J Crohns Colitis; 2019 Mar; 13(4):472-481. PubMed ID: 30423034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Aneuploidy and Flat Dysplasia With Development of High-Grade Dysplasia or Colorectal Cancer in Patients With Inflammatory Bowel Disease.
    Tsai JH; Rabinovitch PS; Huang D; Small T; Mattis AN; Kakar S; Choi WT
    Gastroenterology; 2017 Dec; 153(6):1492-1495.e4. PubMed ID: 28843957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.
    van Schaik FD; ten Kate FJ; Offerhaus GJ; Schipper ME; Vleggaar FP; van der Woude CJ; Stokkers PC; de Jong DJ; Hommes DW; van Bodegraven AA; Siersema PD; Oldenburg B;
    Inflamm Bowel Dis; 2011 May; 17(5):1108-16. PubMed ID: 20824815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
    Löfberg R
    Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colitis-associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer.
    Söderlund S; Tribukait B; Öst Å; Broström O; Karlén P; Löfberg R; Askling J; Sjöqvist U
    Inflamm Bowel Dis; 2011 May; 17(5):1101-7. PubMed ID: 20853434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L; Lapidus A; Ost A; Bergquist A
    Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
    Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia in inflammatory bowel disease.
    Greenson JK
    Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidy.
    Sjöqvist U; Befrits R; Söderlund S; Ost A; Karlén P; Tribukait B; Rubio C; Rutgeerts P; Geboes K; Löfberg R
    Anticancer Res; 2005; 25(6C):4393-7. PubMed ID: 16334114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
    Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
    Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
    Itzkowitz SH; Harpaz N
    Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis: correlation with clinical characteristics and impact on surveillance.
    Holzmann K; Klump B; Borchard F; Gregor M; Porschen R
    Dis Colon Rectum; 2001 Oct; 44(10):1446-55. PubMed ID: 11598473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
    Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT
    Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
    Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis.
    Lindberg JO; Stenling RB; Rutegård JN
    Br J Surg; 1999 Jul; 86(7):947-50. PubMed ID: 10417571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.